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Venous ulcer diagnosis, treatment, and prevention
of recurrences
David L. Gillespie, MD, on behalf of writing group III of the Pacific Vascular Symposium 6,
Rochester, NYThe high incidence and prevalence of chronic venous
disease has a considerable impact on health care. Advanced
venous disease manifested by edema, skin changes such as
lipodermatosclerosis (LDS), and leg ulceration affects over
2.5 million patients per year in the United States.1 Using
the CEAP classification the severity of venous disease may
be categorized from the most benign form of the disease
telengiectasia and reticular veins (C1), through LDS (C4)
to the most debilitating form of the disease, chronic venous
ulceration (C6).2 Studies report that as the average venous
ulcer requires as long as 6 to 12 months to heal completely
and as many as 70% will recur within 5 years of closure.3
These ulcers are often painful and cause loss of an estimated
2 million workdays because of disability. The cost for
treating patients with chronic venous ulcers per year in the
United States is estimated to exceed $3 billion per year.4,5
The charge of our group was to present current princi-
ples in venous ulcer diagnosis and management that will
lead to a reduction in the incidence and prevalence of
venous ulcers in the future. It will be organized under three
major headings of: Diagnosis and Definition of Venous
Ulcer; Treatment of Venous Ulcer; and Prevention of
Venous Ulcer Recurrence.
DEFINITION, DIAGNOSIS, AND BRIEF
PATHOPHYSIOLOGY OF THE VENOUS ULCER
There is no current established official definition of a
venous ulcer, yet we know that venous ulcers constitute the
largest segment of leg ulcers, thought to comprise 50% to 70%
of cases. These estimates are currently agreed upon, even in
the absence of agreement about the elements needed to
classify an ulcer as of venous origin in whole or in part.
According to the revised CEAP classification of chronic
venous disease published in 2004, a venous ulcer is defined
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8Sas a full-thickness defect of skin, most frequently in ankle
region, that fails to heal spontaneously and is sustained by
chronic venous disease.6
The currently proposed initiative plans to decrease
venous ulcers by 50% in 10 years. This proposed ulcer
reduction plan will utilize the following working diagnosis
of a venous leg ulceration: A full thickness defect of the skin
(1) located in the lower leg, typically with pigmentation
and/or skin changes; (2) presence or history of venous
disease: documented history of DVT, or documented axial
venous reflux or deep vein obstruction; and (3) absence of
another condition that could be the essential cause of the
ulcer.
Systematically, we can summarize the definition of a
venous ulcer as a defect in the skin with surrounding
pigmentation and dermatitis, located in the lower leg (usu-
ally in the gaiter region) that has been present for greater
than 30 days, characterized by persistent venous hyperten-
sion and abnormal venous function (result of venous reflux
and/or obstruction confirmed by hemodynamic and/or
physiologic assessment), without a primary or associated
arterial, immunologic, endocrine, or systemic cause. It is
recognized that ulcers can be caused purely by venous
pathology such as venous reflux or obstruction.When these
abnormalities are combined with additional pathologic
conditions, they contribute to the causation and perpetua-
tion of the ulcer. The latter situation includes comorbid
conditions such as arterial ischemia, swelling and lymphed-
ema, trauma, autoimmune disorders, neurotrophic condi-
tions, and diabetic vascular disease.7 These ulcers are cate-
gorized as mixed origin, in which the venous component
may or may not play a dominant role. Successful treatment
of such ulcers includes not only the venous component but
also concomitant management of the comorbid condition.
A diagnosis of venous reflux or obstruction must be
established by an objective test beyond the routine clinical
examination of the extremity. Many conditions result in
discoloration of the skin. Tissue changes alone such as
those seen in a classical “post-phlebitic” appearance are not
adequate for a diagnosis without definitive documentation
of reflux or obstruction in the veins of the extremity.
Currently, duplex scanning, which is widely available, is
considered the standard test of choice.
Further complicating the situation is the wide practice
variation and levels of expertise of those individuals per-
forming the duplex scans within the United States. The
scan required for the diagnosis of venous hemodynamic
abnormalities requires a complete assessment of the venous
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tion, standard for diagnosis of venous thrombosis. This
“extended” scan of venous reflux is time consuming and
not practiced routinely in hospital and non-hospital based
vascular laboratories in this country for a variety of reasons.
To begin, the time needed and incremental cost for the
additional reflux examination are barriers to widespread
adoption. In addition, there is a lack of demand from the
medical profession for this additional reflux information.
The need for a “standardized chronic venous scan” that
includes analysis of the extremity for axial venous reflux is a
practical problem that must be solved before a 50% reduc-
tion in venous ulcers can be achieved.
Complete duplex examinations of lower extremities
with venous disease have been widely reported in patients
with venous ulceration. These studies have shown that the
distribution and extent of reflux is strongly associated with
the clinical severity of chronic venous insufficiency (CVI).
Distal venous reflux is present in at least 80% of the symp-
tomatic limbs. Patients with venous ulcers exhibit involve-
ment of the superficial veins in 90% or more of cases,
perforator involvement in 80% or more, and deep vein
involvement in 70% or more.8-18 Of note, deep venous
thrombosis (DVT) is not a prerequisite for the develop-
ment of skin changes or ulceration. Labropoulos et al found
that 86% (37/43) of patients with venous ulcers have some
degree of reflux in the local area, the pattern of which may
differ from the axial vein disease and in support of the
concept that treatment of the local hemodynamic abnor-
malities is an important factor in the healing of the ulcers
and in the prevention of their recurrence.9
To date, there are no effective therapies preventing skin
fibrosis or identifying patients who may be at risk for
developing venous ulcers. Early identification of patients at
risk for fibrosis associated with venous insufficiency may
lead to therapies that could prevent the progression of
benign disease to lipodermatosclerosis (LDS) and non-
healing ulceration. A potential clue in the pathogenesis of
progression to LDS and non-healing ulceration can be
found in research evaluating the important regulators of
tissue remodeling.
One important factor identified is transforming growth
factor- (TGF-), which has been widely studied in wound
healing. The expression of both the type I and type II
TGF- receptors has been shown to be elevated in acute
wounds.19 In addition in the acute wound, TGF- has
been shown to stimulate the synthesis of extracellular ma-
trix proteins20 and suppress their degradation by decreasing
protease expression.21 These regulatory mechanisms allow
for normal wound healing to occur. Conversely, venous
ulcer fibroblasts demonstrate a lack of viable TGF- recep-
tor complexes, which may contribute to the chronicity of
these wounds.22
Various studies have implied that there are abnormali-
ties in the TGF- signaling pathway in chronic venous
ulcerations.23-27 The degree of skin hardening or fibrosis
associated with LDS is proposed to relate directly to skin
breakdown and venous ulcer formation as well as to asubsequent delay in ulcer healing.19 In fibroblasts derived
from patients with C6 disease, there is a lack of type II
TGF- receptor present in ulcer biopsies.22 Interestingly,
TGF--RII is observed in the fibroblasts and inflammatory
cells surrounding the ulcer. Healing ulcers were shown to
express both type I and type II receptors suggesting that
the presence of a viable receptor complex is necessary for
healing. These results, however, have not been correlated
with the clinical data found in patients with C6 disease.
Most recently, analyses of fibroblasts from chronic wounds
have shown alterations in the TGF- signaling pathway and
decreased TGF--RII expression.28 Furthermore, venous
ulcer fibroblasts have been shown to be unresponsive with
respect to collagen synthesis.29
Recommendations and actions regarding the
diagnosis of a venous ulcer
For more patients to receive an accurate diagnosis and
effective treatment for venous ulcerations, an increase in
clinician education is required. The educational process
should be directed to clinicians who treat patients as they
access the health care system, such as primary care clinics,
nurse practitioner, and physician assistant run centers, and
even the emergency room. An initial diagnostic workup for
a patient with a leg ulcer should include a venous duplex
scan and an arterial evaluation (ABI) to ensure that com-
pression therapy can safely be employed. The importance of
early and accurate venous duplex scanning when skin
changes or ulcers first occur is fundamental to prompt
treatment and limitation of dense scarring of the lower leg
tissues. Both of these tests should be performed by a
qualified diagnostic vascular laboratory (eg, ICVAL accred-
ited). The clinical history should focus on signs and symp-
toms that elicit a venous cause of the ulcer. These criteria
may include leg heaviness and cramps, swelling, leg pain
after ambulating that is relieved with rest and elevation, and
a history of deep venous thrombosis.
The role of the primary care physician in this process is
critical because the treatment of early skin changes or ulcers
increase the chance to preserve the tissues of the lower leg.
A major educational program is needed to enroll primary
care clinicians as key members of the team to reduce venous
ulcers through recognition of these early cases. The educa-
tional message to primary providers is that chronic venous
disease is a lifelong progressive degenerative process, much
like peripheral arterial disease. Effective management prior
to irreversible skin changes will prevent marked disability in
the patient’s later life.
A call to action for all primary care providers to perform
the necessary venous duplex scans and classify leg ulcers as
venous, nonvenous, or mixed etiology is sorely needed.
Effective management in the early stages of chronic venous
insufficiency involves more than just getting the ulcer to
heal. It requires that a cause of the ulcer is established, and
the necessary steps to eliminate or control venous reflux or
obstruction are taken. The primary care provider should
refer patients to a center where a definitive diagnosis and
proper treatment can be made if they lack the expertise.
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care includes wound care clinics and a growing field of
venous specialists.
A strong public awareness campaign is also needed to
alert patients with progressive venous disease to contact
their physician for diagnostic evaluation and definitive care.
Too often, the patient’s early inquiry may be overlooked by
the physician as a minor problem that can delay definitive
evaluation and preventive management.
Specific means to improve the diagnosis of venous
ulcer
The need for development of standardized diagnostic
evaluations and increased education for primary care pro-
viders throughout the USA will take several years. This
proposal is setting a goal for achieving the initial diagnosis
by venous duplex scan within 1 week of presentation by
50% of wound practitioners in 3 years. The 5-year goal
increases this benchmark to 75% of practitioners diagnosing
venous disease through duplex scanning within the first
week of presentation. The methods for achieving this in-
clude a major program of awareness, utilizing medical
resources from wound care clinic organizations, Health
Maintenance Organizations, the Veterans Administration,
Medicare, and intense efforts from medical societies.
The adoption and dissemination of this information
could be fostered through the creation of a patient “venous
ulcer card” that documents the ABI (or presence of arterial
pedal pulses) and the presence of reflux or obstruction in
the leg/pelvic veins. This could extend to a Website docu-
mentation form and other mechanisms to store and dissem-
inate the data.
Monitoring progress of this project over the next de-
cade is paramount but is challenging. Recording, on a
national scale, the number of leg ulcers referred for venous
testing, the results of the testing categorized for pure and
mixed venous ulcers according to a single definition, mon-
itoring the time to referral for venous testing, and the
numbers of recurrent ulcerations would be ideal. This
might be possible as data abstraction improves and as more
and more hospital systems engage the electronic medical
record. The progression of venous disease could be cap-
tured according to a definitive diagnosis, and the results of
various treatments could ultimately be compared.
TREATMENT OF VENOUS ULCERS
While the primary aim for the treatment of venous
ulcers requires a paradigm change from healing to one of
prevention, the discussion in this section will be restricted
to appropriate therapy targeted to ulcer healing. Definitive
care of the ulcer patient now needs to be extended from just
healing the ulcer to correction of treatable venous reflux
and obstructive states and to ongoing surveillance of those
whose disease is not correctable.
The literature on venous ulceration has focused largely
upon means to reverse the inflammatory changes around
the ulcer and achieve epithelial covering of the ulcer defect.
The vital importance of compression to eliminate swellingand reverse the derangement of the microcirculation is well
recognized by many informed physicians but poorly prac-
ticed across the spectrum of primary care providers. It is not
uncommon to encounter patients who have been under a
physician’s care for persistent venous ulceration for weeks,
months, and even years using a variety of therapies, but
without objective testing for venous disease or treatment
with any compression modality.
Judging from experience because accurate reports are
not available, it could well be that over half of patients with
venous ulcers in the general public are managed by their
physician without the use of compression. The reason for
this is failure to disseminate basic knowledge about the
effects of swelling and venous hypertension exists through
our entire system of medical education. The majority of
medical schools do not include lectures on this subject in
their curriculum. The same is true for postgraduate training
programs in general medicine, and for qualifying examina-
tions in general and specialty medicine, in spite of the
occurrence of chronic venous disease in over 20% of the
adult population. Thus, the busy practitioner is likely to be
uneducated about chronic venous disease and poorly
equipped to provide proper care for patients with VU.
The importance of reducing edema is central to the
appropriate management of all lesions of the distal lower
extremity in the erect human being. For the venous ulcer
patient, it is absolutely vital that lower leg and ankle swell-
ing be controlled. Elimination of swelling is a prerequisite
for the effective use of all other medications including
antibiotics and both medicinal and physical applications to
the wound surface in the ambulant care of the venous
ulcer.30,31
The management of venous ulceration has progressed
from recommendations for prolonged bed rest and eleva-
tion of the leg to ambulatory treatment using effective
support. The principles of effective compression and active
ambulation have been advanced through the studies of
Partsch, Stemmer, and others in Europe, and the develop-
ments of the stocking and bandaging industries.32-34
Evidence-based guidelines exist for the treatment of venous
ulcers.35, 36 The Cochrane Collaboration review of 39
randomized controlled trials examining various forms of
compression in venous leg ulcers concluded that compres-
sion clearly increases ulcer healing rates compared with no
compression.37 Multicomponent systems are more effec-
tive than single-component systems, and most studies
found that multicomponent systems with an elastic ban-
dage were more effective than those composed mainly of
inelastic components.
Compliance with compression is difficult to assess in
long-term follow-up. According to a survey including a
large cohort of patients under the care of primary care
physicians and specialists, 63% of patients did not use the
compression stockings prescribed, with no differences be-
tween the C0-C2 and the C3-C6 group.38
The role of various medications and applications for the
wound surface is beyond the scope of this document.
Proper wound bed preparation, including controlling bac-
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to facilitate the healing process.39 However, topical thera-
pies are usually unsuccessful in stimulating wound healing
without definitive care of the underlying venous abnormal-
ity, and concomitant compression.
The role that correction of superficial reflux and iliac
venous obstruction plays in promoting ulcer healing re-
mains to be defined. Prospective, randomized studies have
not confirmed that venous intervention will result in faster
ulcer healing, but clearly show that ulcers treated in this way
recur less often.30,40-42 However, we believe that evalua-
tion of the iliac venous system should be considered if
persistent ulcer and edema exist, despite correcting super-
ficial venous reflux and compliance with compression gar-
ments.43 In addition to superficial and iliac vein disease,
other sources of primary axial reflux include incompetent
perforator veins, focal reflux through the small saphenous
vein, and deep axial reflux with focal incompetence through
local perforator veins.
Studies are not available to show whether corrective
venous procedures should be done while the ulcer is active
or delayed until the ulcer heals. Logically, the optimal time
to intervene would be as early in the course of chronic
venous disease as one can determine that the extremity is at
risk for the development of advanced leg tissue changes. In
this way, the integrity of the soft tissue in the lower leg
could be preserved. For the present, it can only be said that
surgical intervention to correct treatable reflux and ob-
struction is essential to decrease the overall incidence of
VUs.
The problem of ulcers related to postthrombotic syn-
drome (PTS) is more complicated and will be addressed in
a separate manuscript later in this issue. There are those
with combinations of PTS and superficial primary reflux
disease where elimination of the superficial reflux is of great
benefit in limiting progression of the subcutaneous soft
tissue changes.44 For PTS, level 1 evidence exists for the
benefit of long-term use of graduated support in decreasing
recurrences of the ulcer and in providing patient com-
fort.30,32
While not able to be addressed easily because of multi-
ple socioeconomic reasons, many venous ulcer patients are
infirm, live alone, and are often morbidly obese without
adequate support systems. It seems that a disproportionate
percent of CVU patients become wards of the community
because their health habits are chronically deficient, their
diets often result in obesity, and their access to informed
medical care early in the course of the venous disease has
been limited. For these, programs to heighten awareness
and promote education of the medical and para-medical
professions are the best hope within our present medical
system.
Recommendations and actions for treatment of
venous ulcer
(1) When an ulcer patient is initially seen by a primary care
provider, an accurate diagnosis is the most importantfirst step. This may require referral to a source such as a
wound care clinic or a venous-schooled practitioner
who will obtain the needed venous and arterial testing
and institute immediate application of effective com-
pression therapy. Specifically, an accurately diagnosed
VU case to receive effective compression treatment
within the first week is the goal. This is necessary to
eliminate swelling in the extremity because all other
modalities are largely ineffective until the swelling is
corrected. It is equally important to diagnose cases
where arterial insufficiency coexists with venous disease
complicating treatment due to the risk of compression
therapy in this patient group. These patients should be
referred initially to specialist centers for management.
(2) Specific correction of treatable sources of axial reflux
and deep vein obstruction are critical to the control of
venous hypertension and its long-term destructive ef-
fects upon the soft tissue of the lower leg. Early referral
to a venous specialist is advised if the practitioner is not
capable of more advanced management.
(3) Active cooperation with the wound care clinics is
needed to adjust treatment algorithms for early diag-
nosis and definitive treatment of venous ulcerations.
Wound care clinics, along with the movement to de-
velop informed specialists in venous diseases, are the
best sources for unifying a definitive approach to ve-
nous ulcer management.
(4) A strong educational program is needed to inform
primary care providers about their role in guiding the
patient with his/her first venous ulcer to achieve an
accurate diagnosis. Providing this initial effort, defini-
tive care can be instituted before the lower leg tissues
become irretrievably scarred. Programs to improve
treatment of VU patients could include web-based
guidelines about VU treatment and risks of recurrence
of ulcer to heighten awareness, programs with CME
accreditation for physicians at various levels, incorpora-
tion of questions about chronic venous disease on
board certification examinations for primary care phy-
sicians, and residency review committee physician
training documentation.
(5) Major programs of patient and patient’s family aware-
ness are needed to treat the venous ulcer case early and
effectively, and to prevent the chronic progression of
the venous hypertension to the level that results in
lower leg tissue scarring and ulceration effects.
PREVENTION OF ULCER RECURRENCE
The primary goal after a VU has healed should be the
avoidance of recurrence. Chronic venous patients are prone
to develop new sites of involvement over time, and the
ongoing venous dysfunction tends to become more de-
structive to the lower leg tissues as aging occurs in the erect
human. Progression from asymptomatic varicose veins to
severe lipodermatosclerosis is estimated to occur in about
20% of cases. The aim of treatment in all patients needs to
focus on preventing the gradual progression of the venous
hypertension to the point of lower leg tissue scarring with
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contrast to other types of leg ulcer, healing of the
ulcerated skin defect does very little to prevent a new
ulcer from forming if the underlying cause for the ulcer
remains intact. For example, a VU is much more likely to
recur if the underlying reflux or obstruction is not
treated and/or the patient is noncompliant with com-
pression therapy. Ulcer recurrence is a huge problem for
which effective remedies are available for a significant
number of cases, but not for all.
As stated in the prior section, the ideal treatment for
venous ulceration is to remove or repair the veins with
reflux or obstruction so the underlying cause of the ulcer
ceases to exist. This will also significantly decrease the
recurrence rate. When the ulcer is first diagnosed, it will be
found to be due to either primary reflux disease or post-
thrombotic deep vein obstruction/reflux disease. In the
case of primary reflux, the venous abnormality is nearly
always correctable in whole or in part by superficial venous
ablation of the routes of axial reflux. When this is done, the
pathologic process is eliminated or decreased, and the venous
physiology is returned to a more normal state. Since it is
established that 40% to 70% of VUs are secondary to
primary reflux disease, it is clear that this treatment alone
will result in marked reduction of venous ulcers.45 These
patients should be referred initially to specialist centers for
management. The frequency of recurrent ulcer will be
markedly reduced by this treatment and that is superior to
treatment by compression alone.30,41,42
The rate of VU recurrence has been found by some to
depend upon the degree of compliance with compression
treatment, but has also been reported to vary with the
etiology of the disease, the extent of deep vein involvement,
the type of therapy, and the duration of follow-up.36,46-50
Current evidence suggests that recurrence of venous ulcer-
ation is decreased by ablation of reflux in the superficial
venous system more effectively than compression
alone.36,40,42,51-53 For example, the beneficial effect of
venous surgery over compression alone comes from Gohel
et al 36 in a study where 500 patients with open or recently
healed leg ulcers and superficial venous reflux were ran-
domized to either compression treatment alone or in com-
bination with superficial venous surgery. Twenty-four-
week healing rates were similar in both groups (65% vs 65%,
hazard 0·84 [95% CI 0·77 to 1·24]; P  .85), but 12-
month ulcer recurrence rates were reduced in the compres-
sion and surgery group (12% vs 28%, hazard 2·76 [95%
CI1·78 to4·27]; P .0001). Longer follow-up of the
same patient series reported similar superiority at 3 years
when the recurrences had mounted to 56% for those who
had only compression compared to 31% recurrence when
surgical treatment was added.
The availability of this treatment may present the best
single opportunity for reduction of venous ulcers, as evi-
denced by the successful Swedish report of VU reduction
by Nelzen et al.45,54 A protocol that identifies patients with
superficial reflux among the VU population and treats them
effectively could reduce the incidence of VU by a signifi-cant portion of the 50% goal. In fact, it is probable that the
goal to decrease the incidence of VU cannot succeed until
the several routes of reflux are routinely identified by accu-
rate ultrasound diagnosis and effectively treated in the
community setting.
The technique of venous ablation is not critical as long
as the venous reflux is addressed. In the prospective ran-
domized study, Zamboni et al treated 47 legs with venous
ulcers with either superficial venous surgery, using a mini-
mally invasive surgical hemodynamic correction of reflux
(CHIVA) or with compression.42 All patients had primary
superficial vein incompetence. Patients with PTS, deep vein
reflux or obstruction, or those with excessive ulcers (12
cm) were excluded. At 3 years, healing was 100% (31 days)
in the surgical and 96% (63 days) in the compression group
(P  .02). The recurrence rate was 9% in the surgical and
38% in the compression group (P  .05).
Elimination of other routes of axial superficial and local
perforator reflux in primary disease is also readily done by
minimally invasive procedures through accurate noninvasive
ultrasound tracing of reflux patterns in the ulcer patients.
These include small saphenous reflux, focal perforator reflux
serving the ulcer bed, especially when accompanied by axial
deep reflux, and various cases of recurrent ulceration after
prior reflux ablations have developed new sites of reflux.
Patients with combined superficial and deep axial reflux are
candidates in selected instances for elimination of the su-
perficial axial reflux combined with ongoing use of external
support to decrease the incidence of recurrent ulceration.
Recommendations and actions to prevent ulcer
recurrence
(1) Compression, correction, and surveillance are the three
key actions to effective prevention of ulcer recurrence.
Compression is needed in virtually all cases of VU at
the beginning of treatment and continuing as long as
the risk exists for recurrence. Correction of venous
reflux and obstruction is important because it elimi-
nates the basic cause of the sustained venous hyper-
tension and may effectively cure the problem. Surveil-
lance refers to ongoing follow up of the VU patient to
detect new sites of reflux or thrombosis, and to prompt
treatment of new problems before they cause tissue
damage. Long-term maintenance of effective external
compression is needed for all who have swelling in the
legs.
(2) The VU case does not end with epithelialization of the
wound. Educating the primary and specialty physicians
that the VU patient has a chronic disease that needs a
program of ongoing external compression and surveil-
lance against recurrent reflux or thrombosis.
(3) Education is needed in the medical profession and in
the public perception of chronic venous disease. Two
widely held and seriously misleading concepts are that
chronic venous disease is not treatable and ulcers are
not preventable. These need to be corrected by the
understanding that chronic venous disease is readily
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sound scanning and that a large proportion of the ulcer
cases can be effectively treated. Chronic venous disease
has to be understood to be a lifelong degenerative
condition whose management belongs in the responsi-
bility of the primary physician as well as the interven-
tional specialist.
Means to prevent recurrence of venous ulcer
(1) Creation of a guideline for fundamental change in the
responsibility of those who treat VU patients to include
prevention of ulcer recurrence along with healing of
the skin ulcer defect. Early referral to a venous specialist
is advised if the practitioner is not capable of more
advanced management
This would embrace the following principles of treat-
ment:
(a) Correct axial superficial reflux and other readily
correctable sources of reflux and obstruction in all
ulcer cases where practical during the treatment
phase of the first ulcer.
(b) Maintain effective compression therapy on the ul-
cerated extremity as long as the underlying cause
of the ulcer remains uncorrected and as long as
swelling occurs in the dependent leg.
(c) Manage the VU patient as any other chronic debil-
itating disorder by ongoing surveillance as long as
underlying reflux and obstruction persists in the
extremity.
(2) Develop cooperation with the wound care clinics of the
United States to incorporate accurate venous reflux
scans in all leg ulcer patients that are suspect for a
venous etiology, and add correction of the treatable
sources of venous reflux and obstruction in their treat-
ment algorithm.
(3) Develop guidelines for ongoing surveillance that apply
to all who care for patients with chronic venous disease
and especially for patients with venous ulceration.
These guidelines should embrace correction of treat-
able venous reflux and obstruction, and ongoing effec-
tive compression for PTS.
(4) Develop an adequately powered research program that
will provide high-quality evidence to confirm or deny
that correction of axial superficial reflux (C2 disease),
and perhaps other specific sources of ulcer develop-
ment, results in delay or prevention of advanced ve-
nous (C4-C6) disease.
(5) Incorporate the primary care physician in the early
diagnosis and effective management of chronic venous
disease. Chronic venous disease should be viewed by
the medical profession as a lifelong progressive disor-
der with the threat of becoming a debilitating disorder
in its later stages for a significant proportion (20%) of
cases. As such, it requires the attention of the primary
care physician to diagnose its presence and manage its
early stages.BENCHMARK MEASURES AND TIMELINE OF
SUCCESS FOR VENOUS ULCER HEALING AND
RECURRENCE
(1) A 50% compliance with early employment of compres-
sion therapy in VU care in 2 years, and 75% in 5 years.
(2) Guidelines for diagnosis of VU via chronic duplex scan
with compliance of 80% in wound clinics and specialty
venous clinics in 3 years, and 100% in 5 years.
(3) A 50% compliance by wound care clinics and venous
specialty clinics with interventional treatment to elimi-
nate superficial venous reflux and other selective
sources of focal axial reflux in 3 years, and 80% compli-
ance in 5 years.
(4) Awareness programs for the public and educational
programs for the health care profession within 1 year.
(5) Adoption of the concept that chronic venous disease is
a lifelong progressive degenerative disorder by 50% of
primary care medical societies in 5 years.
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